Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Stem cell transplantation for neurodegenerative diseases

Rosser, Anne Ea,b; Zietlow, Rikeb; Dunnett, Stephen Bb

doi: 10.1097/WCO.0b013e3282f132fc
Degenerative and cognitive diseases: Edited by Sarah Tabrizi and Geraint Rees
Buy

Purpose of review To review recent developments in the application of stem cells for transplantation therapies in neurodegenerative diseases.

Recent findings Stem cell transplantation has the potential to improve function by replacing cells lost to the disease and reconstructing elements of neural circuitry or by providing support for host cells (e.g. by secretion of trophic factors). Other mechanisms, such as modulation of the immune system by bone marrow stem cell transplantation, pertinent to conditions such as multiple sclerosis, are emerging as therapies but will not be discussed here. There have been substantial advances in our understanding of stem cell biology and some recent important advances in controlling their differentiated phenotype. Using stem cells to provide trophic support places less stringent requirements on the cells and this is the area in which many of the first clinical studies are taking place.

Summary There are real prospects of stem cell technology having a place in clinical management of neurodegenerative conditions, but directing the differentiation of stem cells towards the appropriate neural phenotype remains a challenge. This is a relatively new and rapidly evolving area, and caution should be applied when advising patients.

aDepartments of Neurology and Genetics, School of Medicine, Cardiff University, Heath Park, UK

bLife Sciences Building, Cardiff University School of Biosciences, Museum Avenue, Cardiff, UK

Correspondence to Professor Anne Rosser, Professor of Clinical Neuroscience, Cardiff University, Departments of Neurology and Genetics, School of Medicine, Heath Park, Cardiff CF14 4XN, UK Tel: +44 (0)2920875188; e-mail: rosserae@cf.ac.uk

© 2007 Lippincott Williams & Wilkins, Inc.